Sunita D. Nasta, MD, gives her perspective on emerging treatments for peripheral T-cell lymphomas.
Sunita D. Nasta, MD
Advertisement
Articles by Sunita D. Nasta, MD
Advertisement
Latest Updated Articles
Making Progress in PTCL: Significant Unmet NeedsPublished: May 13th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Sevabertinib in Non-Squamous NSCLC
2
Tarlatamab Earns Traditional FDA Approval in ES-SCLC
3
FDA OKs Selumetinib in NF1 Symptomatic, Inoperable Plexiform Neurofibromas
4
FDA Traditionally Approves Daratumumab Regimen in AL Amyloidosis
5
